Is DEA putting a telehealth controlled substance registry on the table?
Healthcare It News
AUGUST 7, 2023
WHY IT MATTERS The DEA said in its notice that it is conducting public listening sessions to get input on prescribing controlled substances on telemedicine platforms and to learn about the availability and types of data that would be useful in detecting diversion and potential safeguards that could effectively prevent and detect the diversion.
Let's personalize your content